跳至主要内容
临床试验/KCT0006092
KCT0006092进行中(未招募)未知

Administration of autologous total IgG in patient with severe atopic dermatitis of refractory to dupilumab treatment

Ajou University Hospital0 个研究点目标入组 1 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
进行中(未招募)
发起方
入组人数
1

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional Study

入排标准

年龄范围
19(Year) 至 0No Limit(—)
性别
All

入选标准

  • 1. Adult patients with recalcitrant atopic dermatitis (age = 19 years) whose clinical conditions has not been effectively controlled by dupilumab treatment.
  • 2. Compatible with the criteria for autologous blood donation (body weight =32 kg)

排除标准

  • Exclusion criteria
  • 1) Patients under the age of 19 year.
  • 2) Patients who are unable to agree on their own (emergency patients, patients with mental disability, patients with limited capacity to consent due to stroke or delirium caused by diabetes).
  • 3) Patients with severe disease whose expected survival duration is less than 3 months.

研究者

发起方
Ajou University Hospital

相似试验